SlideShare a Scribd company logo
1 of 33
LIVER FUNCTION TESTS
DR SUNNY CHOPRA
LFT’S
 ……..Group of biochemical tests used for diagnosis
and monitoring of liver disease
 Hepatic Physiology:
 Largest solid organ in the body
 Performs over 500 chemical processes
 Produces over 160 different proteins
BASIC PROCESSES IN LIVER DISEASES
• Acute &Chronic
Hepatitis
• Cirrhosis
Liver cell
damage
• Intra hepatic
cholestasis
• Extra hepatic
cholestasis
Biliary tract
involvement
CLASSIFICATION OF LFT’S
Group 1
• Tests based on Excretory Functions
Group 2
• Tests based on Synthetic Functions
Group 3 • Tests based on Serum Enzymes
Group 4
• Tests based on Metabolic Functions/ Special tests
Group 5
• Markers of Hepatic fibrosis
GROUP 1- TESTS BASED ON EXCRETORY
FUNCTIONS
 SERUM- Total bilirubin, conjugated and un-
conjugated bilirubin
 URINE – Bile pigments, bile salts and urobilinogen
ESTIMATION OF BILIRUBIN
GROUP 1- ESTIMATION OF BILIRUBIN
 Serum Bilirubin:
Total bilirubin: 0.2–1.0 mg/dl
Conjugated bilirubin: 0-0.4 mg/dl
Un-conjugated bilirubin: 0.4-1.0mg/dl
Jaundice > 2mg/dl
(Serum bilirubin is elevated, when excretion
capacity of liver is decreased to 50%)
GROUP 1- URINE FINDINGS
 Urinary - Bilirubin & Urobilinogen
 Pre-Hepatic/ Hemolytic jaundice:
Urobilinogen ++
Bilirubin -- (acholuric jaundice)
 Obstructive jaundice:
Urobilinogen --
Bilirubin ++ (choluric jaundice)
GROUP 1- FECES FINDINGS
 Bilirubin in feces: Normally not present.
 Fecal Urobilinogen : 50-250mg/day
 Hemolytic jaundice - Dark colored feces
 Obstructive jaundice– Clay colored feces
 Malignant obstruction- Complete absence of fecal
Urobilinogen
Findings Hemolytic
jaundice
Obstructive
jaundice
Hepatocellular
jaundice
Total Bilirubin Elevated Elevated Elevated
Conjugated
Bilirubin
Normal Elevated Elevated
Unconjugated
Bilirubin
Elevated Normal Elevated
Bile pigments
(urine)
Absent +++ ++
Bile Salts
(urine)
Absent ++ +
Urobilinogen
(urine)
Elevated Absent Normal or less
BROMOSULFTHALEIN (BSP)TEST
(EXCRETORY FUNCTION)
 Very Sensitive Test
 Single bolus dose of BSP – 5mg/kg bw
 Serum concentration at 25 mtns and 45
mtns are measured
 Normal cases – retention is <5% at 45 mtns
 Increased retention - Useful to detect mild
impairment/ index of Liver damage
 (Contraindication - Obstructive jaundice)
GROUP-2
TEST BASED ON SYNTHETIC FUNCTIONS
1. Serum Total proteins: 5.5 - 8.0 g/dl
2. Albumin: synthesized exclusively in liver
 3.5 - 5.0 g/dL (Half-life:15-20 days)
Impaired synthesis in hepatic dysfunction, (cirrhosis-
<3.0g/dl)
 severity of hypoalbuminemia α degree of damage
 Low albumin after treatment is poor prognostic sign
GROUP-2
TEST BASED ON SYNTHETIC FUNCTIONS
3. Globulin: gamma globulin levels increased in
chronic conditions of liver
4. A:G Ratio : 1.5-2.5
reversed in cirrhosis
 Severity of Hypoalbuminemia α Degree of damage
 Low albumin after treatment is poor prognostic
sign
GROUP-2
TEST BASED ON SYNTHETIC FUNCTIONS
5. Prothrombin Time:
 Except factor VIII, all Clotting factors are
synthesized by liver
 PT collectively measure factor II, V, VII and X.
 10-13 sec
 Time increased in acute and chronic liver diseases
(Vit K should normal)
GROUP-3
TESTS BASED ON SERUM ENZYMES
1. Enzymes indicating Hepatocellular
damage (ALT, AST)
2. Enzymes indicating Cholestasis (ALP,
GGTP,5’NT)
GROUP-3 (ALT/SGPT)
 More liver specific enzyme
 Half-life 47hrs
 Present in cytosol of hepatocytes and
released with mild cell damage (necrosis),
inflammation (hepatitis), drug toxicity.
 Normal range: 5-40 U/L
 Decrease levels indicates response to
treatment and good prognosis.
alanine -ketoglutarate pyruvate glutamate
Aminotransferase (Transaminase)
COO
CH2
CH2
C
COO
O
CH3
HC
COO
NH3
+
COO
CH2
CH2
HC
COO
NH3
+
CH3
C
COO
O
+ +
GROUP-3 (AST/ SGOT)
 Found in heart, liver, muscle, intestine,
pancreas
 Not very specific for liver disease
 Normal range: 5- 30 U/L
 In liver 20% activity is cytosolic and 80%
mitochondrial
 Elevated 2 or 3:1 (vs. ALT) in alcoholics
(AST/ SGOT)
aspartate -ketoglutarate oxaloacetate glutamate
Aminotransferase (Transaminase)
COO
CH2
CH2
C
COO
O
COO
CH2
HC
COO
NH3
+
COO
CH2
CH2
HC
COO
NH3
+
COO
CH2
C
COO
O
+ +
AST/ALT RATIO (0.8)
 < 1 : liver disease
 >2
 Extra-hepatic source
 Alcoholic hepatitis
 Liver metastasis
 MI
 Erythromycin treatment
 >4 : fulminant Wilson’s disease
GROUP- 3
(ALKALINE PHOSPHATASE)
Markers of Cholestasis
 ALP – liver and bone (placenta, kidneys,
intestine, breast)
 Normal Range: 3-13 KAU/dl, 40-125U/L
 Moderate increase 2-3 times - hepatic
disease
 High levels (10-12) - extra or intra hepatic
obstruction
 V high levels (10-25) - bone disease
GROUP 3 (GGT)
 catalyzed transfer of γ-glutamyl groups of
peptides to other amino acid
 11 isoenzymes, abundant in liver, kidney,
pancreas, intestine, and prostate, spleen, heart,
brain but not in bone
 Normal range: 10-30U/L
 Along with ALP …good marker of cholestasis
GROUP 3 (GGT)
 T1/2
 7-10 days (28 days in alcohol-associated
liver injury)
 Very sensitive to detect alcohol abuse
 GGT levels in alcoholic liver disease parallels
alcohol intake
GROUP-4
TESTS BASED ON METABOLIC FUNCTIONS
 Estimation of iron profile:
serum iron
serum ferritin
Galactose tolerance test
Fructose tolerance test
GROUP-4
TESTS BASED ON METABOLIC FUNCTIONS
 Galactose tolerance test:
 Basis: Normal Liver is able to convert Galactose
into glucose
 Procedure: 40 gm orally or 0.5 gm/kgBW I/V is
given
 Blood samples are collected at ½ hr intervals
 Interpretation: 3gm or less Gal is excreted in urine
& normal gal in serum
 Parenchymatous disease: Excretion is more
 Can be done in Jaundice
GROUP- 4
TESTS BASED ON METABOLIC FUNCTIONS
 Fructose tolerance test
 Epinephrine tolerance test :
 Principle: Response to epinephrine is evidenced
by elevation of Blood sugar and is directly
influenced by Glycogen stores of liver
 Interpretation: Parenchymal and Glycogen storage
disease
GROUP- 5
MARKERS OF HEPATIC FIBROSIS
1.Direct Markers
 SHA (serum hyaluronic acid)
 PICP(procollagen type carboxy terminal peptide
 MMP (matrix metalloproteinases)
2. Indirect Markers
 AST/ALT ratio
 Platelet count
 Apolipoprotein A1
Advantages
• sensitive, noninvasive
method of screening liver
dysfunction
• pattern of laboratory test
abnormalities to recognize
type of liver disorder
• assess severity of liver
dysfunction
• follow cause of liver
disease
Disadvantages
• lack sensitivity
– normal results in serious
liver disease
• not specific for liver
dysfunction
• seldom lead to specific
diagnosis
LIVER FUNCTION TEST
THANK
YOU

More Related Content

What's hot

What's hot (20)

Liver function tests
Liver function testsLiver function tests
Liver function tests
 
LFT
LFTLFT
LFT
 
Liver function test
Liver function testLiver function test
Liver function test
 
Liver and Liver function tests
Liver and Liver function testsLiver and Liver function tests
Liver and Liver function tests
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function test
Liver function testLiver function test
Liver function test
 
Liver Function test
Liver Function testLiver Function test
Liver Function test
 
Evaluation of liver function tests ppt
Evaluation of liver function tests pptEvaluation of liver function tests ppt
Evaluation of liver function tests ppt
 
liver function test
liver function testliver function test
liver function test
 
Liver function tests Dr.r.mallika
Liver function tests  Dr.r.mallikaLiver function tests  Dr.r.mallika
Liver function tests Dr.r.mallika
 
A batch 1 st group
A batch 1 st groupA batch 1 st group
A batch 1 st group
 
Commonly done liver function tests
Commonly done liver function tests Commonly done liver function tests
Commonly done liver function tests
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function test
Liver function testLiver function test
Liver function test
 
Liver function test (LFT)
Liver function test (LFT)Liver function test (LFT)
Liver function test (LFT)
 
LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)
 
Liver function test
Liver function testLiver function test
Liver function test
 
liver function test for mbbbs
liver function test  for mbbbsliver function test  for mbbbs
liver function test for mbbbs
 
Approach to lft
Approach to lftApproach to lft
Approach to lft
 
Liver Function Tests
Liver Function Tests Liver Function Tests
Liver Function Tests
 

Similar to Lft f lect

Liver functions, disorders and diagnostic tests - ppt
Liver  functions, disorders and diagnostic tests - pptLiver  functions, disorders and diagnostic tests - ppt
Liver functions, disorders and diagnostic tests - ppt
Teja Naveen
 

Similar to Lft f lect (20)

LFTx. clinical pharmacy, PharmD 4th year
LFTx. clinical pharmacy, PharmD 4th yearLFTx. clinical pharmacy, PharmD 4th year
LFTx. clinical pharmacy, PharmD 4th year
 
O.F.T. with liver and kidney functions.pdf
O.F.T. with liver and kidney functions.pdfO.F.T. with liver and kidney functions.pdf
O.F.T. with liver and kidney functions.pdf
 
liver function test
liver function testliver function test
liver function test
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
 
Liver functions, disorders and diagnostic tests - ppt
Liver  functions, disorders and diagnostic tests - pptLiver  functions, disorders and diagnostic tests - ppt
Liver functions, disorders and diagnostic tests - ppt
 
INTERPRETATION OF COMMON BIOCHEMICAL TESTS INCLUDING LFT & RFT.pptx
INTERPRETATION OF COMMON BIOCHEMICAL TESTS INCLUDING LFT & RFT.pptxINTERPRETATION OF COMMON BIOCHEMICAL TESTS INCLUDING LFT & RFT.pptx
INTERPRETATION OF COMMON BIOCHEMICAL TESTS INCLUDING LFT & RFT.pptx
 
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
 
Liver fxn
Liver fxnLiver fxn
Liver fxn
 
liver_function_tests.ppt
liver_function_tests.pptliver_function_tests.ppt
liver_function_tests.ppt
 
LFT,RFT,TFT.pptx
LFT,RFT,TFT.pptxLFT,RFT,TFT.pptx
LFT,RFT,TFT.pptx
 
LFT nursing.PPT
LFT nursing.PPTLFT nursing.PPT
LFT nursing.PPT
 
Liver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda JainLiver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda Jain
 
Liver Functions tests
Liver Functions testsLiver Functions tests
Liver Functions tests
 
SILD 2021.pdf
SILD 2021.pdfSILD 2021.pdf
SILD 2021.pdf
 
Diagnosis of Liver Disease in Dogs & Cats
Diagnosis of Liver Disease in Dogs & Cats Diagnosis of Liver Disease in Dogs & Cats
Diagnosis of Liver Disease in Dogs & Cats
 
Evaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasEvaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemias
 
Liver Function Tests (LFTs)
Liver Function Tests (LFTs)Liver Function Tests (LFTs)
Liver Function Tests (LFTs)
 
Interpretation of Liver function test
Interpretation of  Liver function testInterpretation of  Liver function test
Interpretation of Liver function test
 
liver 1-27.6.2014.ppt
liver 1-27.6.2014.pptliver 1-27.6.2014.ppt
liver 1-27.6.2014.ppt
 
Liver Tests
Liver TestsLiver Tests
Liver Tests
 

Recently uploaded

MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MysoreMuleSoftMeetup
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
中 央社
 
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdfContoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
cupulin
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
Peter Brusilovsky
 

Recently uploaded (20)

Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of TransportBasic Civil Engineering notes on Transportation Engineering & Modes of Transport
Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
 
The Story of Village Palampur Class 9 Free Study Material PDF
The Story of Village Palampur Class 9 Free Study Material PDFThe Story of Village Palampur Class 9 Free Study Material PDF
The Story of Village Palampur Class 9 Free Study Material PDF
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
Trauma-Informed Leadership - Five Practical Principles
Trauma-Informed Leadership - Five Practical PrinciplesTrauma-Informed Leadership - Five Practical Principles
Trauma-Informed Leadership - Five Practical Principles
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
 
Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...
 
UChicago CMSC 23320 - The Best Commit Messages of 2024
UChicago CMSC 23320 - The Best Commit Messages of 2024UChicago CMSC 23320 - The Best Commit Messages of 2024
UChicago CMSC 23320 - The Best Commit Messages of 2024
 
An overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismAn overview of the various scriptures in Hinduism
An overview of the various scriptures in Hinduism
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
PSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptxPSYPACT- Practicing Over State Lines May 2024.pptx
PSYPACT- Practicing Over State Lines May 2024.pptx
 
VAMOS CUIDAR DO NOSSO PLANETA! .
VAMOS CUIDAR DO NOSSO PLANETA!                    .VAMOS CUIDAR DO NOSSO PLANETA!                    .
VAMOS CUIDAR DO NOSSO PLANETA! .
 
male presentation...pdf.................
male presentation...pdf.................male presentation...pdf.................
male presentation...pdf.................
 
Supporting Newcomer Multilingual Learners
Supporting Newcomer  Multilingual LearnersSupporting Newcomer  Multilingual Learners
Supporting Newcomer Multilingual Learners
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
 
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdfContoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
Analyzing and resolving a communication crisis in Dhaka textiles LTD.pptx
Analyzing and resolving a communication crisis in Dhaka textiles LTD.pptxAnalyzing and resolving a communication crisis in Dhaka textiles LTD.pptx
Analyzing and resolving a communication crisis in Dhaka textiles LTD.pptx
 

Lft f lect

  • 1. LIVER FUNCTION TESTS DR SUNNY CHOPRA
  • 2. LFT’S  ……..Group of biochemical tests used for diagnosis and monitoring of liver disease  Hepatic Physiology:  Largest solid organ in the body  Performs over 500 chemical processes  Produces over 160 different proteins
  • 3.
  • 4.
  • 5. BASIC PROCESSES IN LIVER DISEASES • Acute &Chronic Hepatitis • Cirrhosis Liver cell damage • Intra hepatic cholestasis • Extra hepatic cholestasis Biliary tract involvement
  • 6. CLASSIFICATION OF LFT’S Group 1 • Tests based on Excretory Functions Group 2 • Tests based on Synthetic Functions Group 3 • Tests based on Serum Enzymes Group 4 • Tests based on Metabolic Functions/ Special tests Group 5 • Markers of Hepatic fibrosis
  • 7. GROUP 1- TESTS BASED ON EXCRETORY FUNCTIONS  SERUM- Total bilirubin, conjugated and un- conjugated bilirubin  URINE – Bile pigments, bile salts and urobilinogen
  • 8.
  • 10. GROUP 1- ESTIMATION OF BILIRUBIN  Serum Bilirubin: Total bilirubin: 0.2–1.0 mg/dl Conjugated bilirubin: 0-0.4 mg/dl Un-conjugated bilirubin: 0.4-1.0mg/dl Jaundice > 2mg/dl (Serum bilirubin is elevated, when excretion capacity of liver is decreased to 50%)
  • 11. GROUP 1- URINE FINDINGS  Urinary - Bilirubin & Urobilinogen  Pre-Hepatic/ Hemolytic jaundice: Urobilinogen ++ Bilirubin -- (acholuric jaundice)  Obstructive jaundice: Urobilinogen -- Bilirubin ++ (choluric jaundice)
  • 12. GROUP 1- FECES FINDINGS  Bilirubin in feces: Normally not present.  Fecal Urobilinogen : 50-250mg/day  Hemolytic jaundice - Dark colored feces  Obstructive jaundice– Clay colored feces  Malignant obstruction- Complete absence of fecal Urobilinogen
  • 13. Findings Hemolytic jaundice Obstructive jaundice Hepatocellular jaundice Total Bilirubin Elevated Elevated Elevated Conjugated Bilirubin Normal Elevated Elevated Unconjugated Bilirubin Elevated Normal Elevated Bile pigments (urine) Absent +++ ++ Bile Salts (urine) Absent ++ + Urobilinogen (urine) Elevated Absent Normal or less
  • 14. BROMOSULFTHALEIN (BSP)TEST (EXCRETORY FUNCTION)  Very Sensitive Test  Single bolus dose of BSP – 5mg/kg bw  Serum concentration at 25 mtns and 45 mtns are measured  Normal cases – retention is <5% at 45 mtns  Increased retention - Useful to detect mild impairment/ index of Liver damage  (Contraindication - Obstructive jaundice)
  • 15. GROUP-2 TEST BASED ON SYNTHETIC FUNCTIONS 1. Serum Total proteins: 5.5 - 8.0 g/dl 2. Albumin: synthesized exclusively in liver  3.5 - 5.0 g/dL (Half-life:15-20 days) Impaired synthesis in hepatic dysfunction, (cirrhosis- <3.0g/dl)  severity of hypoalbuminemia α degree of damage  Low albumin after treatment is poor prognostic sign
  • 16. GROUP-2 TEST BASED ON SYNTHETIC FUNCTIONS 3. Globulin: gamma globulin levels increased in chronic conditions of liver 4. A:G Ratio : 1.5-2.5 reversed in cirrhosis  Severity of Hypoalbuminemia α Degree of damage  Low albumin after treatment is poor prognostic sign
  • 17. GROUP-2 TEST BASED ON SYNTHETIC FUNCTIONS 5. Prothrombin Time:  Except factor VIII, all Clotting factors are synthesized by liver  PT collectively measure factor II, V, VII and X.  10-13 sec  Time increased in acute and chronic liver diseases (Vit K should normal)
  • 18. GROUP-3 TESTS BASED ON SERUM ENZYMES 1. Enzymes indicating Hepatocellular damage (ALT, AST) 2. Enzymes indicating Cholestasis (ALP, GGTP,5’NT)
  • 19. GROUP-3 (ALT/SGPT)  More liver specific enzyme  Half-life 47hrs  Present in cytosol of hepatocytes and released with mild cell damage (necrosis), inflammation (hepatitis), drug toxicity.  Normal range: 5-40 U/L  Decrease levels indicates response to treatment and good prognosis.
  • 20. alanine -ketoglutarate pyruvate glutamate Aminotransferase (Transaminase) COO CH2 CH2 C COO O CH3 HC COO NH3 + COO CH2 CH2 HC COO NH3 + CH3 C COO O + +
  • 21. GROUP-3 (AST/ SGOT)  Found in heart, liver, muscle, intestine, pancreas  Not very specific for liver disease  Normal range: 5- 30 U/L  In liver 20% activity is cytosolic and 80% mitochondrial  Elevated 2 or 3:1 (vs. ALT) in alcoholics
  • 22. (AST/ SGOT) aspartate -ketoglutarate oxaloacetate glutamate Aminotransferase (Transaminase) COO CH2 CH2 C COO O COO CH2 HC COO NH3 + COO CH2 CH2 HC COO NH3 + COO CH2 C COO O + +
  • 23. AST/ALT RATIO (0.8)  < 1 : liver disease  >2  Extra-hepatic source  Alcoholic hepatitis  Liver metastasis  MI  Erythromycin treatment  >4 : fulminant Wilson’s disease
  • 24. GROUP- 3 (ALKALINE PHOSPHATASE) Markers of Cholestasis  ALP – liver and bone (placenta, kidneys, intestine, breast)  Normal Range: 3-13 KAU/dl, 40-125U/L  Moderate increase 2-3 times - hepatic disease  High levels (10-12) - extra or intra hepatic obstruction  V high levels (10-25) - bone disease
  • 25. GROUP 3 (GGT)  catalyzed transfer of γ-glutamyl groups of peptides to other amino acid  11 isoenzymes, abundant in liver, kidney, pancreas, intestine, and prostate, spleen, heart, brain but not in bone  Normal range: 10-30U/L  Along with ALP …good marker of cholestasis
  • 26. GROUP 3 (GGT)  T1/2  7-10 days (28 days in alcohol-associated liver injury)  Very sensitive to detect alcohol abuse  GGT levels in alcoholic liver disease parallels alcohol intake
  • 27. GROUP-4 TESTS BASED ON METABOLIC FUNCTIONS  Estimation of iron profile: serum iron serum ferritin Galactose tolerance test Fructose tolerance test
  • 28. GROUP-4 TESTS BASED ON METABOLIC FUNCTIONS  Galactose tolerance test:  Basis: Normal Liver is able to convert Galactose into glucose  Procedure: 40 gm orally or 0.5 gm/kgBW I/V is given  Blood samples are collected at ½ hr intervals  Interpretation: 3gm or less Gal is excreted in urine & normal gal in serum  Parenchymatous disease: Excretion is more  Can be done in Jaundice
  • 29. GROUP- 4 TESTS BASED ON METABOLIC FUNCTIONS  Fructose tolerance test  Epinephrine tolerance test :  Principle: Response to epinephrine is evidenced by elevation of Blood sugar and is directly influenced by Glycogen stores of liver  Interpretation: Parenchymal and Glycogen storage disease
  • 30. GROUP- 5 MARKERS OF HEPATIC FIBROSIS 1.Direct Markers  SHA (serum hyaluronic acid)  PICP(procollagen type carboxy terminal peptide  MMP (matrix metalloproteinases) 2. Indirect Markers  AST/ALT ratio  Platelet count  Apolipoprotein A1
  • 31.
  • 32. Advantages • sensitive, noninvasive method of screening liver dysfunction • pattern of laboratory test abnormalities to recognize type of liver disorder • assess severity of liver dysfunction • follow cause of liver disease Disadvantages • lack sensitivity – normal results in serious liver disease • not specific for liver dysfunction • seldom lead to specific diagnosis LIVER FUNCTION TEST